United Therapeutics Corp
NASDAQ:UTHR 4:00:00 PM EDT
| Market Cap (Intraday) | 18.26B |
| Current PE | 14.70 |
| Forward PE | 14.86 |
| 2yr Forward PE | 13.88 |
| 10-Day MA | $394.40 |
| 50-Day MA | $326.90 |
| 200-Day MA | $326.17 |
United Therapeutics Corp Stock, NASDAQ:UTHR
1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305
Description
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.